rs61755047

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_000270.4(PNP):​c.679G>A​(p.Val227Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00115 in 1,613,988 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0061 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00064 ( 10 hom. )

Consequence

PNP
NM_000270.4 missense

Scores

6
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 5.56

Publications

5 publications found
Variant links:
Genes affected
PNP (HGNC:7892): (purine nucleoside phosphorylase) This gene encodes an enzyme which reversibly catalyzes the phosphorolysis of purine nucleosides. The enzyme is trimeric, containing three identical subunits. Mutations which result in nucleoside phosphorylase deficiency result in defective T-cell (cell-mediated) immunity but can also affect B-cell immunity and antibody responses. Neurologic disorders may also be apparent in patients with immune defects. A known polymorphism at aa position 51 that does not affect enzyme activity has been described. A pseudogene has been identified on chromosome 2. [provided by RefSeq, Jul 2008]
PNP Gene-Disease associations (from GenCC):
  • purine nucleoside phosphorylase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000270.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a chain Purine nucleoside phosphorylase (size 288) in uniprot entity PNPH_HUMAN there are 12 pathogenic changes around while only 3 benign (80%) in NM_000270.4
BP4
Computational evidence support a benign effect (MetaRNN=0.016106158).
BP6
Variant 14-20476410-G-A is Benign according to our data. Variant chr14-20476410-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 390920.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00607 (924/152270) while in subpopulation AFR AF = 0.0209 (867/41552). AF 95% confidence interval is 0.0197. There are 9 homozygotes in GnomAd4. There are 454 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000270.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNP
NM_000270.4
MANE Select
c.679G>Ap.Val227Ile
missense
Exon 6 of 6NP_000261.2P00491

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PNP
ENST00000361505.10
TSL:1 MANE Select
c.679G>Ap.Val227Ile
missense
Exon 6 of 6ENSP00000354532.6P00491
PNP
ENST00000556293.6
TSL:1
n.3102G>A
non_coding_transcript_exon
Exon 3 of 3
PNP
ENST00000557229.6
TSL:1
n.1108G>A
non_coding_transcript_exon
Exon 4 of 4

Frequencies

GnomAD3 genomes
AF:
0.00603
AC:
917
AN:
152152
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00145
AC:
365
AN:
251484
AF XY:
0.00115
show subpopulations
Gnomad AFR exome
AF:
0.0193
Gnomad AMR exome
AF:
0.000896
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000967
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000642
AC:
938
AN:
1461718
Hom.:
10
Cov.:
31
AF XY:
0.000542
AC XY:
394
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.0222
AC:
744
AN:
33476
American (AMR)
AF:
0.00123
AC:
55
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000405
AC:
45
AN:
1111874
Other (OTH)
AF:
0.00126
AC:
76
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
56
112
169
225
281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00607
AC:
924
AN:
152270
Hom.:
9
Cov.:
32
AF XY:
0.00610
AC XY:
454
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0209
AC:
867
AN:
41552
American (AMR)
AF:
0.00307
AC:
47
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
49
97
146
194
243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00245
Hom.:
5
Bravo
AF:
0.00732
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
Purine-nucleoside phosphorylase deficiency (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.039
Eigen_PC
Benign
0.062
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.90
D
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
-0.11
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.6
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.90
N
REVEL
Benign
0.27
Sift
Benign
0.041
D
Sift4G
Benign
0.13
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.46
gMVP
0.60
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs61755047;
hg19: chr14-20944569;
COSMIC: COSV64091945;
COSMIC: COSV64091945;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.